Abstract
Objective
To investigate the effects of Clean-DM1 (C-DM1), a polyherbal formulation of Radix Scrophulariae, Radix Astragali, Rhizoma Atractylodis, and Radix Salviae Miltiorrhizae, on high-fat diet (HFD)-induced diabetes mice.
Methods
The information about active components of C-DM1 extract and molecular mechanism was obtained from network pharmacology analysis. Main compounds of C-DM1 extract by high performance liquid chromatography-mass spectrometry (HPLC-MS) analysis were conducted for quality control. For in vivo study, mice were induced diabetes by HFD for 12 weeks. The mice in the normal group (Nor) were maintained with a regular diet and treated with saline by gavage. The HFD model mice were randomly divided into 3 groups, including a HFD diabetic model group, a C-DM1 extract-administered group (C-DM1, 500 mg/kg), and metformin-administered groups (Met, 500 mg/kg), 8 mice in each group. Food intake, body weight (BW), and fasting blood glucose (FBG) levels were recorded weekly for 4 weeks. After 4 weeks of treatment, alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood glucose, low-density lipoprotein cholesterol (LDL-C) were determined using an automated clinical chemistry analyzer, and homeostatic model for assessing insulin resistance (HOMA-IR) levels and oral glucose tolerance test (OGTT) were detected. The histopathological changes of liver and pancreatic tissues were observed by hematoxylin-eosin staining. Insulin receptor substrate (IRS)/phosphatidylinositol 3 kinase (PI3K)/ protein kinase B (AKT) and adenosine 5′-monophosphate-activated protein kinase (AMPK) expressions in liver and pancreas tissues were detected by Western blot analysis.
Results
HPLC-MS identified dihydroisotanshinone, dihydroisotanshinone I, cryptotanshinone, harpagoside, and atractyloside A in C-DM1 extract. The administration of C-DM1 extract significantly decreased body weight, calorie intake, and the levels of blood glucose and insulin in the diabetic mice (P<0.05 or P<0.01). The C-DM1 extract administration improved the impaired glucose tolerance and insulin resistance in the diabetic mice and significantly decreased the levels of LDL-C, ALT and AST (P<0.01). The C-DM1 extract inhibited the histopathological changes of fatty liver and hyperplasia of pancreatic islets in the diabetic mice. The C-DM1 extract significantly increased the phosphorylation of IRS, AKT, and AMPK and the expression of PI3K in pancreas and liver tissues (P<0.05 or P<0.01), which was consistent with the analysis results of network pharmacology.
Conclusion
C-DM1 extract improved diabetes symptoms in long-term HFD-induced mice by regulation of IRS/PI3K/AKT and AMPK expressions in pancreas and liver tissues, suggesting that C-DM1 formulation may help prevent the progression of T2DM.
Similar content being viewed by others
References
Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. The Lancet 2017;389:2239–2251.
Apovian CM, Okemah J, O’Neil PM. Considerations in the management of type 2 diabetes. Adv Ther 2019;36:44–58.
Reed J, Bain S, Kanamarlapudi V. A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives. Diabetes Metab Syndr Obes 2021;14:3567–3602.
Lian F, Ni Q, Shen Y, Yang S, Piao C, Wang J, et al. International traditional Chinese medicine guideline for diagnostic and treatment principles of diabetes. Ann Palliat Med 2020;9:2237–2250.
Kim XX, Li LX, Li YZ, An DJ, Li SR, Xu RP, et al. Textbook compilation committee. Herbology, 3nd ed; Seoul: Younglim: Academic Press; 1998:233,331,458,577.
WHO. ICD-11 for mortality and morbidity statistics, 26, Supplementary chapter traditional medicine conditions-module. Available at: https://icd.who.int/dev11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f718687701 (Accessed June 1, 2021).
Zhang GB, Li QY, Chen QL, Su SB. Network pharmacology: a new approach for Chinese herbal medicine research. Evid Based Complement Alternat Med 2013;621423.
Lu XY, Zhou FH, Dong YQ, Gong LN, Li QY, Tang L, et al. Codonopsis tangshen Oliv. amelioration effect on diabetic kidney disease rats induced by high fat diet feeding combined with streptozotocin. Nat Prod Bioprospect 2018;8:441–451.
Zhang N, Li Z, Yu H, Liu G, Zhao H, Dong W, et al. Antidiabetic activity of Radix Scrophulariae and its split fraction. Pharmacol Clin Chin Materia Medica (Chin) 2016;32:55–60.
Chen Y, Chen J, Chou G. Research review on chemical constituent and pharmacological action of Rhizoma Atractylodis. Acad J Shanghai Univ Tradit Chin Med (Chin) 2006;20:95–98.
Duan G, Ouyang Z, Fan Y, Wu R, Han L. Studies on atractylodes polysaccharides on lowering blood glucose of mice. Chin Arch Tradit Chin Med (Chin) 2008;26:1211–1212.
Jia Q, Zhu R, Tian Y, Chen B, Li R, Li L, et al. Salvia miltiorrhiza in diabetes: a review of its pharmacology, phytochemistry, and safety. Phytomedicine 2019;58:152871.
Hwang SB, Lee BH. Anti-obesity and antidiabetic effects of Nelumbinis Semen Powder in high-fat diet-induced obese C57BL/6 mice. Nutrients 2020;12:3576.
Li S, Fan TP, Jia W, Lu A, Zhang W. Network pharmacology in traditional Chinese medicine. Evid Based Complement Alternat Med 2014;2014:138460.
Højlund K. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Dan Med J 2014;61:B4890.
Meng X, Ma J, Kang AN, Kang SY, Jung HW, Park YK. A novel approach based on metabolomics coupled with intestinal flora analysis and network pharmacology to explain the mechanisms of action of Bekhogainsam Decoction in the improvement of symptoms of streptozotocin-induced diabetic nephropathy in mice. Fron Pharmacol 2020;11:633.
Xiao E, Luo L. Alternative therapies for diabetes: a comparison of Western and traditional Chinese medicine (TCM) approaches. Curr Diabetes Rev 2018;14:487–496.
Zhang Z, Zhang L, Xu H. Effect of Astragalus polysaccharide in treatment of diabetes mellitus: a narrative review. J Tradit Chin Med 2019;39:133–138.
Chen X, Wang DD, Wei T, He SM, Zhang GY, Wei QL. Effects of astragalosides from Radix Astragali on high glucose-induced proliferation and extracellular matrix accumulation in glomerular mesangial cells. Exp Ther Med 2016;11:2561–2566.
Pedro PF, Tsakmaki A, Bewick GA. The glucose tolerance test in mice. Methods Mol Biol 2020;2128:207–216.
Seong J, Kang JY, Sun JS, Kim KW. Hypothalamic inflammation and obesity: a mechanistic review. Arch Pharm Res 2019;42:383–392.
Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2009;5:150–159.
Lee K, Han J, Kim SG. Increasing risk of diabetes mellitus according to liver function alterations in electronic workers. J Diabetes Investig 2014;5:671–676.
Yang HW, Son M, Choi J, Oh S, Jeon YJ, Byun K, et al. Ishige okamurae reduces blood glucose levels in high-fat diet mice and improves glucose metabolism in the skeletal muscle and pancreas. Fish Aquatic Sci 2020;23:24.
Aboul-Mahasen LM, Abdulrahman AR. The possible protective effects of virgin olive oil and Nigella sativa seeds on the biochemical and histopathological changes in pancreas of hyperlipidaemic rats. Folia Morphol (Warsz) 2019;78:762–772.
Ho CK, Sriram G, Dipple KM. Insulin sensitivity predictions in individuals with obesity and type II diabetes mellitus using mathematical model of the insulin signal transduction pathway. Mol Genet Metab 2016;119:288–292.
Rahman MS, Hossain KS, Das S. Role of insulin in health and disease: an update. Int J Mol Sci 2021;22:6403.
Liou CJ, Lee YK, Ting NC, Chen YL, Shen SC, Wu SJ, et al. Protective effects of Licochalcone A ameliorates obesity and non-alcoholic fatty liver disease via promotion of the Sirt-1/AMPK pathway in mice fed a high-fat diet. Cells 2019;8:447.
Lee ES, Kwon MH, Kim HM, Woo HB, Ahn CM, Chung CH. Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity. Metabolism 2020;103:154015.
Borén J, Taskinen MR, Olofsson SO, Levin M. Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med 2013;274:25–40.
Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 2016;126:12–22.
Singh H, Ganneru S, Malakapalli V, Chalasani M, Nappanveettil G, Bhonde RR, et al. Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats. Islets 2014;6:e998099.
Beale EG. Insulin signaling and insulin resistance. J Investig Med 2013;61:11–14.
Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell 2017;169:381–405.
Ueda-Wakagi M, Hayashibara K, Nagano T, Ikeda M, Yuan S, Ueda S, et al. Epigallocatechin gallate induces GLUT4 translocation in skeletal muscle through both PI3K- and AMPK-dependent pathways. Food Funct 2018;9:4223–4233.
Dinda B, Dinda M, Roy A, Dinda S. Dietary plant flavonoids in prevention of obesity and diabetes. Adv Protein Chem Struct Biol 2020;120:159–235.
Bähr I, Bazwinsky-Wutschke I, Wolgast S, Hofmann K, Streck S, Mühlbauer E, et al. GLUT4 in the endocrine pancreas—indicating an impact in pancreatic islet cell physiology? Horm Metab Res 2012;44:442–450.
Zhang J, Liu F. Tissue-specific insulin signaling in the regulation of metabolism and aging. IUBMB Life 2014;66:485–495.
Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 2001;108:1631–1638.
Tao R, Gong J, Luo X, Zang M, Guo W, Wen R, et al. AMPK exerts dual regulatory effects on the PI3K pathway. J Mol Signal 2010;5:1–9.
Author information
Authors and Affiliations
Contributions
Liu Y and Wang P contributed equally in this manuscript and completed first draft. Jung HW and Park YK as co-correspondences conceptualized the experiments; Liu Y, Wang P, Kang SY, Ho T and Lee KJ performed in vivo experiments and analyzed the data. Meng X, Lyu C and Han X analyzed network pharmacology and performed HPLC analysis. Jung HW, Park YK and Meng X reviewed and edited the manuscript. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
The authors declare that there is no conflict of interest.
Additional information
Supported by Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), the Ministry of Health & Welfare, Republic of Korea (No. HF20C0121), Shanxi Key Laboratory of Tradition Herbal Medicines Processing (No. 20210901), and the Innovation Team of Shanxi University of Chinese Medicine (No. 2022TD1014)
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Wang, P., Liu, Y., Kang, S.Y. et al. Clean-DM1, a Korean Polyherbal Formula, Improves High Fat Diet-Induced Diabetic Symptoms in Mice by Regulating IRS/PI3K/AKT and AMPK Expressions in Pancreas and Liver Tissues. Chin. J. Integr. Med. 30, 125–134 (2024). https://doi.org/10.1007/s11655-023-3548-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-023-3548-9